Reven announces Phase II Clinical Development plans for upcoming human efficacy trials.  These trials include exploring efficacy as an adjunct therapy for patients suffering Critical Limb Ischemia.  Additional areas of focus in separate trials will be for chronic wound healing and post-surgical recovery support in orthopedic procedures.  Enrollment for these trials is expected to begin summer 2020.